Emerging technologies for understanding platelet diversity
Emerging technologies for understanding platelet diversity
This review discusses our understanding of platelet diversity with implications for the roles of platelets in hemostasis and thrombosis and identifies advanced technologies set to provide new insights. We use the term diversity to capture intrasubject platelet variability that can be intrinsic or governed by the environment and lead to a heterogeneous response pattern of aggregation, clot promotion, and external communication. Using choice examples, we discuss how the use of advanced technologies can provide new insights into the underlying causes of platelet molecular, structural, and functional diversity. As sources of diversity, we discuss the proliferating megakaryocytes with different allele-specific expression patterns, the asymmetrical formation of proplatelets, changes in platelets induced by aging and priming, interplatelet heterogeneity in thrombus organization and stability, and platelet-dependent communications. We provide indications how current knowledge gaps can be addressed using promising technologies, such as next-generation sequencing, proteomic approaches, advanced imaging techniques, multicolor flow and mass cytometry, multifunctional microfluidics assays, and organ-on-a-chip platforms. We then argue how this technology base can aid in characterizing platelet populations and in identifying platelet biomarkers relevant for the treatment of cardiovascular disease.
biomarkers, cardiovascular diseases, hemostasis, megakaryocytes, platelets, thrombosis
540-552
Heemskerk, Johan
ad1edcd5-16b8-46a7-b6b1-fb3334e094c8
West, Jonathan
f1c2e060-16c3-44c0-af70-242a1c58b968
1 May 2022
Heemskerk, Johan
ad1edcd5-16b8-46a7-b6b1-fb3334e094c8
West, Jonathan
f1c2e060-16c3-44c0-af70-242a1c58b968
Heemskerk, Johan and West, Jonathan
(2022)
Emerging technologies for understanding platelet diversity.
Arteriosclerosis, Thrombosis, and Vascular Biology, 42 (5), .
(doi:10.1161/ATVBAHA.121.317092).
Abstract
This review discusses our understanding of platelet diversity with implications for the roles of platelets in hemostasis and thrombosis and identifies advanced technologies set to provide new insights. We use the term diversity to capture intrasubject platelet variability that can be intrinsic or governed by the environment and lead to a heterogeneous response pattern of aggregation, clot promotion, and external communication. Using choice examples, we discuss how the use of advanced technologies can provide new insights into the underlying causes of platelet molecular, structural, and functional diversity. As sources of diversity, we discuss the proliferating megakaryocytes with different allele-specific expression patterns, the asymmetrical formation of proplatelets, changes in platelets induced by aging and priming, interplatelet heterogeneity in thrombus organization and stability, and platelet-dependent communications. We provide indications how current knowledge gaps can be addressed using promising technologies, such as next-generation sequencing, proteomic approaches, advanced imaging techniques, multicolor flow and mass cytometry, multifunctional microfluidics assays, and organ-on-a-chip platforms. We then argue how this technology base can aid in characterizing platelet populations and in identifying platelet biomarkers relevant for the treatment of cardiovascular disease.
Text
ManuscriptText_Review_ATVB-2021-317092_fin
- Accepted Manuscript
Text
ATVBAHA.121.317092
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 1 March 2022
e-pub ahead of print date: 17 March 2022
Published date: 1 May 2022
Additional Information:
Funding Information:
This work is supported by the Landsteiner Foundation for Blood Transfusion Research Grant (No. 1711, J.W.M. Heemskerk), the British Heart Foundation (FS/13/67/30473, J. West) and the Medical Research Council (MC_PC_15078, J. West).
Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
Keywords:
biomarkers, cardiovascular diseases, hemostasis, megakaryocytes, platelets, thrombosis
Identifiers
Local EPrints ID: 457530
URI: http://eprints.soton.ac.uk/id/eprint/457530
ISSN: 1079-5642
PURE UUID: 75a9a215-315e-41b8-8d6a-fb70097a6637
Catalogue record
Date deposited: 10 Jun 2022 16:36
Last modified: 17 Mar 2024 07:18
Export record
Altmetrics
Contributors
Author:
Johan Heemskerk
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics